[Geneva, 5th, June 2025] – Clearview Market Insights (CVMI) forecasts that the global antivenom market will grow from USD 1.32 billion in 2024 to USD 2.51 billion by 2031, representing a compound annual growth rate (CAGR) of 9.6 percent. This expansion is driven by increasing demand from rural healthcare systems, WHO-backed prequalification efforts, and advancements in recombinant...
